Trinity Biotech Stock (NASDAQ:TRIB)


Chart

Previous Close

$0.64

52W Range

$0.48 - $3.55

50D Avg

$0.67

200D Avg

$1.07

Market Cap

$12.09M

Avg Vol (3M)

$53.69K

Beta

0.81

Div Yield

-

TRIB Company Profile


Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

IE

Employees

380

IPO Date

Oct 21, 1992

Website

TRIB Performance


Latest Earnings Call Transcripts


Q1 22Jun 30, 22 | 3:43 PM
Q2 21Sep 09, 21 | 3:42 PM
Q4 20Mar 25, 21 | 2:43 PM

Peer Comparison


TickerCompany
MDXHMDxHealth SA
GTHGenetron Holdings Limited
NDRAENDRA Life Sciences Inc.
CSTLCastle Biosciences, Inc.
ACRSAclaris Therapeutics, Inc.
FONRFONAR Corporation
PREPrenetics Global Limited
STIMNeuronetics, Inc.
XGNExagen Inc.
OLKOlink Holding AB (publ)